Show simple item record

dc.contributor.authorDi Penta, Alessandra
dc.contributor.authorMoreno, Beatriz
dc.contributor.authorReix, Stephanie
dc.contributor.authorFernández Díez, Begoña
dc.contributor.authorVillanueva, Maite
dc.contributor.authorErrea, Oihana
dc.contributor.authorEscala, Nagore
dc.contributor.authorVandenbroeck, Koen
dc.contributor.authorComella, Joan X.
dc.contributor.authorVilloslada, Pablo
dc.date.accessioned2019-03-08T17:31:34Z
dc.date.available2019-03-08T17:31:34Z
dc.date.issued2013-02-19
dc.identifier.citationPLOS ONE 8(2) : (2013) // e54722es_ES
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10810/31948
dc.description.abstractBackground: Demyelination and axonal damage are critical processes in the pathogenesis of multiple sclerosis (MS). Oxidative stress and pro-inflammatory cytokines elicited by inflammation mediates tissue damage. Methods/Principal Findings: To monitor the demyelination and axonal injury associated with microglia activation we employed a model using cerebellar organotypic cultures stimulated with lipopolysaccharide (LPS). Microglia activated by LPS released pro-inflammatory cytokines (IL-1 beta, IL-6 and TNF alpha), and increased the expression of inducible nitric oxide synthase (iNOS) and production of reactive oxygen species (ROS). This activation was associated with demyelination and axonal damage in cerebellar cultures. Axonal damage, as revealed by the presence of non-phosphorylated neurofilaments, mitochondrial accumulation in axonal spheroids, and axonal transection, was associated with stronger iNOS expression and concomitant increases in ROS. Moreover, we analyzed the contribution of pro-inflammatory cytokines and oxidative stress in demyelination and axonal degeneration using the iNOS inhibitor ethyl pyruvate, a free-scavenger and xanthine oxidase inhibitor allopurinol, as well as via blockage of pro-inflammatory cytokines using a Fc-TNFR1 construct. We found that blocking microglia activation with ethyl pyruvate or allopurinol significantly decreased axonal damage, and to a lesser extent, demyelination. Blocking TNF alpha significantly decreased demyelination but did not prevented axonal damage. Moreover, the most common therapy for MS, interferon-beta, was used as an example of an immunomodulator compound that can be tested in this model. In vitro, interferon-beta treatment decreased oxidative stress (iNOS and ROS levels) and the release of pro-inflammatory cytokines after LPS stimulation, reducing axonal damage. Conclusion: The model of neuroinflammation using cerebellar culture stimulated with endotoxin mimicked myelin and axonal damage mediated by the combination of oxidative stress and pro-inflammatory cytokines. This model may both facilitate understanding of the events involved in neuroinflammation and aid in the development of neuroprotective therapies for the treatment of MS and other neurodegenerative diseases.es_ES
dc.description.sponsorshipThis study was supported by the Instituto de Salud Carlos III: FIS PI041445 (MIOTRED) to PV; RETICS program: Red Espanola de Esclerosis Multiple to PV (RD07/0060/001) and KV (RD07/0060/2005); SAIOTEK 2009 program of the Gobierno Vasco, ref. S-PE09UN33 ("ERtek") to KV and the Juan de la Cierva program of the Ministerio de Ciencia y Innovacion (MICINN) to AdP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Sciencees_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectnitric-oxide synthasees_ES
dc.subjectcentral-nervous-systemes_ES
dc.subjectmultiple-sclerosises_ES
dc.subjectdeveloping oligodendrocyteses_ES
dc.subjectin-vitroes_ES
dc.subjectlipopolysaccharidees_ES
dc.subjectremyelinationes_ES
dc.subjectinjuryes_ES
dc.subjectdegenerationes_ES
dc.subjectmicrogliaes_ES
dc.titleOxidative Stress and Proinflammatory Cytokines Contribute to Demyelination and Axonal Damage in a Cerebellar Culture Model of Neuroinflammationes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2013 di Penta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0054722es_ES
dc.identifier.doi10.1371/journal.pone.0054722
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2013 di Penta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's license is described as © 2013 di Penta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.